Atherosclerosis
Matrix metalloproteinases and diabetic vascular complications
Published in Proteomics Weekly, May 23rd, 2005
According to a study from Greece, "Diabetes mellitus (DM) is associated with an increased incidence of cardiovascular events and microvascular complications. These complications contribute to the morbidity and mortality associated with DM. There is increasing evidence supporting a role for matrix metalloproteinases (MMPs) and their inhibitors (tissue inhibitors of matrix metalloproteinases-TIMPs) in the atherosclerotic process. However, the relationship between MMPs/TIMPs and diabetic angiopathy is less well defined."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2005-05-23)
More Articles from Proteomics Weekly
- Apoptosis
Protein kinase C delta studied, role in human neuron apoptosis demonstrated - Cell Differentiation
Epidermal cell differentiation studied, regulation of signaling clarified - Choline Acetyltransferase
Choline acetyltransferase analyzed, peripheral and common type difference noted - Prions
Prion peptide aggregates analyzed, structural and stability correlations noted - Stroke
Stroke studied in aged brain, effects on protein, DNA and stress response shown - Addiction Medicine
Immunostains discern alcoholic steatohepatitis from nonalcoholic disease - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
